{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:01:02Z","timestamp":1794006062534,"version":"4.8.0"},"reference-count":244,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jhep.2025.03.007","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T20:04:21Z","timestamp":1746821061000},"page":"211-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma"],"prefix":"10.1016","volume":"83","author":[{"given":"Marco","family":"Marzioni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Maroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Aabakken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Carpino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"Groot Koerkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Heimbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Lamarca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Saborowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Vilgrain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Nault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2025.03.007_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jhep.2023.03.010","article-title":"EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma","volume":"79","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.03.007_bib2","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/liv.14856","article-title":"Nationwide treatment and outcomes of perihilar cholangiocarcinoma","volume":"41","author":"van Keulen","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2025.03.007_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.03.007_bib4","series-title":"FIPAT.library.dal.ca. Federative international programme for anatomical terminology","article-title":"Terminologia anatomica","year":"2019"},{"key":"10.1016\/j.jhep.2025.03.007_bib5","series-title":"ICD-11 implementation or transition guide","year":"2019"},{"key":"10.1016\/j.jhep.2025.03.007_bib6","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2025.03.007_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","article-title":"Gallbladder cancer","volume":"8","author":"Roa","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jhep.2025.03.007_bib8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.6004\/jnccn.2023.0034","article-title":"Ampullary adenocarcinoma, version 1.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Chiorean","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jhep.2025.03.007_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","article-title":"Cholangiocarcinoma","volume":"7","author":"Brindley","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jhep.2025.03.007_bib10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00000658-199610000-00005","article-title":"Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors","volume":"224","author":"Nakeeb","year":"1996","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib11","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jhep.2022.07.022","article-title":"Current epidemiology of cholangiocarcinoma in Western countries","volume":"77","author":"Vithayathil","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.03.007_bib12","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ejso.2020.09.039","article-title":"Cholangiocarcinoma miscoding in hepatobiliary centres","volume":"47","author":"Selvadurai","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/gutjnl-2023-330029","article-title":"British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma","volume":"73","author":"Rushbrook","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2025.03.007_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jclinpath-2015-203394","article-title":"Comprehensive genomic profiling of extrahepatic cholangiocarcinoma reveals a long tail of therapeutic targets","volume":"69","author":"Lee","year":"2016","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jhep.2025.03.007_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2020.03.008","article-title":"Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma","volume":"73","author":"Montal","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.03.007_bib16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.21037\/hbsn.2019.08.05","article-title":"Comprehensive molecular profiling of extrahepatic cholangiocarcinoma in Chinese population and potential targets for clinical practice","volume":"8","author":"Xue","year":"2019","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.jhep.2025.03.007_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejca.2022.02.013","article-title":"Prognostic impact of FGFR2\/3 alterations in patients with biliary tract cancers receiving systemic chemotherapy: the BITCOIN study","volume":"166","author":"Rizzato","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jhep.2025.03.007_bib18","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/jnci\/djad046","article-title":"Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma","volume":"115","author":"Spencer","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jhep.2025.03.007_bib19","doi-asserted-by":"crossref","first-page":"652","DOI":"10.21037\/jgo.2018.08.18","article-title":"Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targets","volume":"10","author":"Weinberg","year":"2019","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib20","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.21037\/jgo-21-776","article-title":"Specific genomic alterations and prognostic analysis of perihilar cholangiocarcinoma and distal cholangiocarcinoma","volume":"12","author":"Zheng","year":"2021","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib21","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2025.03.007_bib22","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-18-0078","article-title":"Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: potential targets for intervention","volume":"24","author":"Lowery","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2025.03.007_bib23","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.18632\/oncotarget.1943","article-title":"Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups","volume":"5","author":"Simbolo","year":"2014","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.jhep.2025.03.007_bib24","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jhep.2022.11.030","article-title":"Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinoma","volume":"78","author":"Kendre","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.03.007_bib25","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/hep.31110","article-title":"Genomic characterization of cholangiocarcinoma in primary sclerosing cholangitis reveals therapeutic opportunities","volume":"72","author":"Goeppert","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.03.007_bib26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/path.5994","article-title":"Genetic alterations during the neoplastic cascade towards cholangiocarcinoma in primary sclerosing cholangitis","volume":"258","author":"Kamp","year":"2022","journal-title":"J Pathol"},{"key":"10.1016\/j.jhep.2025.03.007_bib27","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1158\/1078-0432.CCR-22-1954","article-title":"Comprehensive molecular characterization of gallbladder carcinoma and potential targets for intervention","volume":"28","author":"Giraldo","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2025.03.007_bib28","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/ng.3030","article-title":"Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway","volume":"46","author":"Li","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2025.03.007_bib29","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jhep.2020.11.033","article-title":"Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes","volume":"74","author":"Nepal","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.03.007_bib30","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/gut.48.6.816","article-title":"Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998","volume":"48","author":"Taylor-Robinson","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2025.03.007_bib31","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0168-8278(02)00297-0","article-title":"Changing international trends in mortality rates for liver, biliary and pancreatic tumours","volume":"37","author":"Khan","year":"2002","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2025.03.007_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/liv.14095","article-title":"Cholangiocarcinoma: epidemiology and risk factors","volume":"39","author":"Khan","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2025.03.007_bib33","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/s41416-023-02460-2","article-title":"Influence of cirrhosis on outcomes of patients with advanced intrahepatic cholangiocarcinoma receiving chemotherapy","volume":"129","author":"d\u2019Abrigeon","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jhep.2025.03.007_bib34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis","volume":"72","author":"Clements","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.03.007_bib35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/bs.acr.2022.03.004","article-title":"Understanding the genetic basis for cholangiocarcinoma","volume":"156","author":"Schmidt","year":"2022","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.jhep.2025.03.007_bib36","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1470-2045(09)70041-5","article-title":"Management of extracolonic tumours in patients with Lynch syndrome","volume":"10","author":"Koornstra","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib37","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/jnci\/djj465","article-title":"Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada","volume":"98","author":"Risch","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jhep.2025.03.007_bib38","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L","article-title":"Cancer risk in mutation carriers of DNA-mismatch-repair genes","volume":"81","author":"Aarnio","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jhep.2025.03.007_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081114","article-title":"Families with BAP1-tumor predisposition syndrome in The Netherlands: path to identification and a proposal for genetic screening guidelines","volume":"11","author":"Chau","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhep.2025.03.007_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cancergen.2020.10.001","article-title":"Intrahepatic cholangiocarcinoma development in a patient with a novel BAP1 germline mutation and low exposure to asbestos","volume":"248\u2013249","author":"Brandi","year":"2020","journal-title":"Cancer Genet"},{"key":"10.1016\/j.jhep.2025.03.007_bib41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.annonc.2022.10.004","article-title":"Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline","volume":"34","author":"Sessa","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib42","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/annonc\/mdz233","article-title":"Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-updagger","volume":"30","author":"Stjepanovic","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib43","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jhep.2022.09.025","article-title":"Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer","volume":"78","author":"Okawa","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.03.007_bib44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1158\/1940-6207.CAPR-21-0189","article-title":"Germline cancer susceptibility gene testing in unselected patients with hepatobiliary cancers: a multi-center prospective study","volume":"15","author":"Uson Junior","year":"2022","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.jhep.2025.03.007_bib45","article-title":"Comprehensive germline and somatic genomic profiles of Chinese patients with biliary tract cancer","volume":"12","author":"Yu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib46","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cncr.32740","article-title":"Germline alterations in patients with biliary tract cancers: a spectrum of significant and previously underappreciated findings","volume":"126","author":"Maynard","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.jhep.2025.03.007_bib47","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.18632\/oncotarget.27224","article-title":"Germline mutations in cancer-predisposition genes in patients with biliary tract cancer","volume":"10","author":"Terashima","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.jhep.2025.03.007_bib48","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1158\/1078-0432.CCR-19-0127","article-title":"Alterations in DNA damage repair genes in primary liver cancer","volume":"25","author":"Lin","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2025.03.007_bib49","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejca.2022.05.004","article-title":"Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma","volume":"171","author":"Rimini","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jhep.2025.03.007_bib50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000529919","article-title":"Durable response after olaparib treatment for perihilar cholangiocarcinoma with germline BRCA2 mutation","volume":"46","author":"Costa","year":"2023","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.jhep.2025.03.007_bib51","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1634\/theoncologist.2016-0415","article-title":"Overall survival and clinical characteristics of BRCA-associated cholangiocarcinoma: a multicenter retrospective study","volume":"22","author":"Golan","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.jhep.2025.03.007_bib52","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.03.007_bib53","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/hep.29730","article-title":"Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis","volume":"67","author":"Ali","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.03.007_bib54","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1053\/j.gastro.2020.05.049","article-title":"Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel disease, based on sex, race, and age","volume":"159","author":"Trivedi","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.03.007_bib55","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/liv.15286","article-title":"Impact on follow-up strategies in patients with primary sclerosing cholangitis","volume":"43","author":"Bergquist","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2025.03.007_bib56","first-page":"317","article-title":"Complete excision of the intrapancreatic portion of choledochal cysts","volume":"183","author":"Ando","year":"1996","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib57","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/bjs.10798","article-title":"Meta-analysis of risk of developing malignancy in congenital choledochal malformation","volume":"105","author":"Ten","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib58","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/ans.17775","article-title":"Defining an optimal surveillance strategy for patients following choledochal cyst resection: results of a systematic review","volume":"92","author":"Koea","year":"2022","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib59","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/archsurg.2011.243","article-title":"Choledochal cyst and associated malignant tumors in adults: a multicenter survey in South Korea","volume":"146","author":"Lee","year":"2011","journal-title":"Arch Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib60","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MOG.0b013e3282fbf9b3","article-title":"Cholangiocarcinoma: lessons from Thailand","volume":"24","author":"Sripa","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jhep.2025.03.007_bib61","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jhep.2005.11.040","article-title":"Cholangiocarcinoma and Clonorchis sinensis infection: a case-control study in Korea","volume":"44","author":"Choi","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.03.007_bib62","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/flgastro-2019-101343","article-title":"Guideline review: British Society of Gastroenterology\/UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis","volume":"12","author":"Nicoletti","year":"2021","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.jhep.2025.03.007_bib63","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1148\/radiology.203.1.9122423","article-title":"Cholangiocarcinoma: delayed CT contrast enhancement patterns","volume":"203","author":"Lacomis","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2025.03.007_bib64","doi-asserted-by":"crossref","DOI":"10.1148\/radiographics.21.suppl_1.g01oc12s97","article-title":"Radiologic spectrum of cholangiocarcinoma: emphasis on unusual manifestations and differential diagnoses","volume":"21","author":"Lee","year":"2001","journal-title":"Radiographics"},{"key":"10.1016\/j.jhep.2025.03.007_bib65","doi-asserted-by":"crossref","first-page":"547","DOI":"10.7326\/0003-4819-139-7-200310070-00006","article-title":"Magnetic resonance cholangiopancreatography: a meta-analysis of test performance in suspected biliary disease","volume":"139","author":"Romagnuolo","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2025.03.007_bib66","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MOG.0b013e328337b311","article-title":"An update on cholangiocarcinoma associated with primary sclerosing cholangitis","volume":"26","author":"Fevery","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jhep.2025.03.007_bib67","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2214\/ajr.177.5.1771095","article-title":"Using CT and cholangiography to diagnose biliary tract carcinoma complicating primary sclerosing cholangitis","volume":"177","author":"Campbell","year":"2001","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jhep.2025.03.007_bib68","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1067\/mge.2002.124206","article-title":"A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures","volume":"55","author":"Rosch","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2025.03.007_bib69","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0748-7983(03)00148-3","article-title":"Klatskin tumors and Klatskin mimicking lesions of the biliary tree","volume":"29","author":"Knoefel","year":"2003","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib70","first-page":"121","article-title":"Klatskin tumors and \u201cKlatskin-mimicking lesions\u201d: our 22-year experience","volume":"111","author":"Tsalis","year":"2019","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.jhep.2025.03.007_bib71","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41395-018-0036-5","article-title":"IgG4-Associated cholangitis in patients resected for presumed perihilar cholangiocarcinoma: a 30-year tertiary care experience","volume":"113","author":"Roos","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.03.007_bib72","doi-asserted-by":"crossref","first-page":"6197","DOI":"10.3748\/wjg.v18.i43.6197","article-title":"Current endoscopic approach to indeterminate biliary strictures","volume":"18","author":"Victor","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.03.007_bib73","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.12659\/MSM.895040","article-title":"Diagnostic accuracy of serum CA19-9 in patients with cholangiocarcinoma: a systematic review and meta-analysis","volume":"21","author":"Liang","year":"2015","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jhep.2025.03.007_bib74","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.4269\/ajtmh.17-0879","article-title":"Biomarkers for the diagnosis of cholangiocarcinoma: a systematic review","volume":"98","author":"Tshering","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jhep.2025.03.007_bib75","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jhep.2021.12.010","article-title":"Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry","volume":"76","author":"Izquierdo-Sanchez","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.03.007_bib76","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"EASL clinical practice guidelines on sclerosing cholangitis","volume":"77","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.03.007_bib77","article-title":"Prognostic factors of resectable perihilar cholangiocarcinoma: a systematic review and meta-analysis of high-quality studies","volume":"14","author":"Liang","year":"2021","journal-title":"Ther Adv Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2025.03.007_bib78","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.hpb.2017.07.004","article-title":"Conditional survival in patients with unresectable perihilar cholangiocarcinoma","volume":"19","author":"Gaspersz","year":"2017","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jhep.2025.03.007_bib79","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.4240\/wjgs.v13.i9.1025","article-title":"Carbohydrate antigen 19-9 as a novel prognostic biomarker in distal cholangiocarcinoma","volume":"13","author":"Jiang","year":"2021","journal-title":"World J Gastrointest Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib80","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.hpb.2019.03.363","article-title":"Prognostic relevance of preoperative bilirubin-adjusted serum carbohydrate antigen 19-9 in a multicenter subset analysis of 179 patients with distal cholangiocarcinoma","volume":"21","author":"Bolm","year":"2019","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jhep.2025.03.007_bib81","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1007\/s10147-022-02175-z","article-title":"Spread of lymph node metastasis and adjuvant therapy for distal cholangiocarcinoma","volume":"27","author":"Kurahara","year":"2022","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib82","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/1457496919832150","article-title":"Differences in prognostic factors and recurrence patterns after curative-intent resection of perihilar and distal cholangiocarcinomas","volume":"109","author":"Sallinen","year":"2020","journal-title":"Scand J Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib83","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.dld.2020.06.045","article-title":"Italian clinical practice guidelines on cholangiocarcinoma - Part I: classification, diagnosis and staging","volume":"52","author":"Cholangiocarcinoma","year":"2020","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2025.03.007_bib84","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.32771","article-title":"AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma","volume":"77","author":"Bowlus","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.03.007_bib85","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.gie.2023.06.007","article-title":"American Society for Gastrointestinal Endoscopy guideline on role of endoscopy in the diagnosis of malignancy in biliary strictures of undetermined etiology: methodology and review of evidence","volume":"98","author":"Fujii-Lau","year":"2023","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2025.03.007_bib86","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000498976","article-title":"Role of ancillary techniques in biliary cytopathology specimens","volume":"64","author":"Layfield","year":"2020","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jhep.2025.03.007_bib87","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.gie.2019.11.025","article-title":"Digital single-operator peroral cholangioscopy-guided biopsy sampling versus ERCP-guided brushing for indeterminate biliary strictures: a prospective, randomized, multicenter trial (with video)","volume":"91","author":"Gerges","year":"2020","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2025.03.007_bib88","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.gie.2015.09.024","article-title":"Diagnostic yield of EUS-guided FNA for malignant biliary stricture: a systematic review and meta-analysis","volume":"83","author":"Sadeghi","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2025.03.007_bib89","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/2303-9027.193597","article-title":"Endoscopic retrograde cholangiopancreatography versus endoscopic ultrasound for tissue diagnosis of malignant biliary stricture: systematic review and meta-analysis","volume":"7","author":"De Moura","year":"2018","journal-title":"Endosc Ultrasound"},{"key":"10.1016\/j.jhep.2025.03.007_bib90","doi-asserted-by":"crossref","first-page":"294","DOI":"10.34172\/mejdd.2021.238","article-title":"Tissue sampling through endoscopic ultrasound-guided fine needle aspiration versus endoscopic retrograde cholangiopancreatographic brushing cytology technique in suspicious malignant biliary stricture","volume":"13","author":"Sobhrakhshankhah","year":"2021","journal-title":"Middle East J Dig Dis"},{"key":"10.1016\/j.jhep.2025.03.007_bib91","doi-asserted-by":"crossref","first-page":"E769","DOI":"10.1055\/s-0043-123186","article-title":"EUS-FNA versus ERCP for tissue diagnosis of suspect malignant biliary strictures: a prospective comparative study","volume":"6","author":"Moura","year":"2018","journal-title":"Endosc Int Open"},{"key":"10.1016\/j.jhep.2025.03.007_bib92","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1007\/s10620-021-07138-4","article-title":"Brush cytology, forceps biopsy, or endoscopic ultrasound-guided sampling for diagnosis of bile duct cancer: a meta-analysis","volume":"67","author":"Yoon","year":"2022","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2025.03.007_bib93","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5946\/ce.2019.053","article-title":"Endoscopic ultrasound-guided fine needle aspiration and endoscopic retrograde cholangiopancreatography-based tissue sampling in suspected malignant biliary strictures: a meta-analysis of same-session procedures","volume":"53","author":"de Moura","year":"2020","journal-title":"Clin Endosc"},{"key":"10.1016\/j.jhep.2025.03.007_bib94","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1477-2574.2011.00298.x","article-title":"Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination","volume":"13","author":"Heimbach","year":"2011","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jhep.2025.03.007_bib95","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/dc.23137","article-title":"Needle tract seeding: an avoidable complication","volume":"42","author":"Tyagi","year":"2014","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jhep.2025.03.007_bib96","article-title":"Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis - the promise of DNA methylation and molecular biomarkers","volume":"2","author":"Vedeld","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2025.03.007_bib97","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/hep.32125","article-title":"Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile","volume":"75","author":"Vedeld","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.03.007_bib98","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13148-016-0299-x","article-title":"Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract","volume":"8","author":"Branchi","year":"2016","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.jhep.2025.03.007_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147627","article-title":"The role of microRNAs in cholangiocarcinoma","volume":"22","author":"Shi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2025.03.007_bib100","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.2147\/CMAR.S158155","article-title":"Diagnostic and prognostic value of microRNAs in cholangiocarcinoma: a systematic review and meta-analysis","volume":"10","author":"Sun","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.jhep.2025.03.007_bib101","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jhep.2023.02.027","article-title":"Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma","volume":"79","author":"Lapitz","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.03.007_bib102","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1007\/s11605-007-0282-0","article-title":"Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis","volume":"11","author":"Nathan","year":"2007","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib103","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jamcollsurg.2016.03.035","article-title":"Postoperative mortality after liver resection for perihilar cholangiocarcinoma: development of a risk score and importance of biliary drainage of the future liver remnant","volume":"223","author":"Wiggers","year":"2016","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib104","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11604-020-01068-3","article-title":"Structured reporting of CT or MRI for perihilar cholangiocarcinoma: usefulness for clinical planning and interdisciplinary communication","volume":"39","author":"Hong","year":"2021","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.jhep.2025.03.007_bib105","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.21037\/qims-20-1303","article-title":"Multidetector computed tomography assessment of vascular involvement in perihilar cholangiocarcinoma","volume":"11","author":"Franken","year":"2021","journal-title":"Quant Imaging Med Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib106","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1259\/bjr\/88405305","article-title":"Radiological staging in patients with hilar cholangiocarcinoma: a systematic review and meta-analysis","volume":"85","author":"Ruys","year":"2012","journal-title":"The Br J Radiol"},{"key":"10.1016\/j.jhep.2025.03.007_bib107","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3348\/kjr.2023.0368","article-title":"Comparison between contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging with magnetic resonance cholangiopancreatography for resectability assessment in extrahepatic cholangiocarcinoma","volume":"24","author":"Yoo","year":"2023","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.jhep.2025.03.007_bib108","doi-asserted-by":"crossref","first-page":"E162","DOI":"10.1055\/a-2005-3679","article-title":"Endoscopic ultrasound in patients with resectable perihilar cholangiocarcinoma: impact on clinical decision-making","volume":"11","author":"de Jong","year":"2023","journal-title":"Endosc Int Open"},{"key":"10.1016\/j.jhep.2025.03.007_bib109","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jhep.2019.01.038","article-title":"(18)F-fluorodeoxyglucose positron emission tomography ((18)FDG-PET) for patients with biliary tract cancer: systematic review and meta-analysis","volume":"71","author":"Lamarca","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.03.007_bib110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00000658-199201000-00005","article-title":"Management strategies in resection for hilar cholangiocarcinoma","volume":"215","author":"Bismuth","year":"1992","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib111","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00000658-200110000-00010","article-title":"Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma","volume":"234","author":"Jarnagin","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib112","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/jhbp.1066","article-title":"Superiority of clinical American Joint Committee on Cancer T classification for perihilar cholangiocarcinoma","volume":"29","author":"Yamada","year":"2022","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jhep.2025.03.007_bib113","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archsurg.2011.771","article-title":"Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients","volume":"147","author":"Nuzzo","year":"2012","journal-title":"Arch Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib114","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/annonc\/mdv279","article-title":"Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram","volume":"26","author":"Groot","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib115","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/SLA.0000000000005103","article-title":"Perihilar cholangiocarcinoma - novel benchmark values for surgical and oncological outcomes from 24 expert centers","volume":"274","author":"Mueller","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib116","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2025.03.007_bib117","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S2468-1253(24)00095-5","article-title":"Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study","volume":"9","author":"Oh","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.03.007_bib118","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00268-012-1638-5","article-title":"Long-term survival in hilar cholangiocarcinoma also possible in unresectable patients","volume":"36","author":"Ruys","year":"2012","journal-title":"World J Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib119","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.surg.2019.01.010","article-title":"Morbidity and mortality after major liver resection in patients with perihilar cholangiocarcinoma: a systematic review and meta-analysis","volume":"165","author":"Franken","year":"2019","journal-title":"Surgery"},{"key":"10.1016\/j.jhep.2025.03.007_bib120","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/bjs\/znad057","article-title":"Multivariable prediction model for both 90-day mortality and long-term survival for individual patients with perihilar cholangiocarcinoma: does the predicted survival justify the surgical risk?","volume":"110","author":"van Keulen","year":"2023","journal-title":"Br J Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib121","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.1097\/HEP.0000000000000659","article-title":"Reply: how to define the futile outcome in patients undergoing surgery for perihilar cholangiocarcinoma","volume":"79","author":"Ratti","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.03.007_bib122","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/j.1440-1746.2012.07287.x","article-title":"Autoimmune cholangitis and cholangiocarcinoma","volume":"27","author":"Li","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.03.007_bib123","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jamcollsurg.2005.07.011","article-title":"Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma","volume":"201","author":"Corvera","year":"2005","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib124","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/SLA.0000000000005641","article-title":"Liver transplantation as a new standard of care in patients with perihilar cholangiocarcinoma? Results from an international benchmark study","volume":"276","author":"Breuer","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib125","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.hpb.2017.04.014","article-title":"Survival after resection of perihilar cholangiocarcinoma in patients with lymph node metastases","volume":"19","author":"Buettner","year":"2017","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jhep.2025.03.007_bib126","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/hep.31077","article-title":"Endoscopic ultrasound\/fine needle aspiration is effective for lymph node staging in patients with cholangiocarcinoma","volume":"72","author":"Malikowski","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.03.007_bib127","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12957-022-02692-1","article-title":"Effects of portal vein resection and hepatic artery resection on long-term survival in Klatskin tumor: a meta-analysis","volume":"20","author":"Song","year":"2022","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib128","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.hpb.2017.10.003","article-title":"Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium","volume":"20","author":"Schimizzi","year":"2018","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jhep.2025.03.007_bib129","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/SLA.0000000000004322","article-title":"Combined vascular resection for locally advanced perihilar cholangiocarcinoma","volume":"275","author":"Mizuno","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2012.04.008","article-title":"Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers","volume":"143","author":"Darwish","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.03.007_bib131","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1007\/s11605-020-04721-4","article-title":"Liver transplantation for peri-hilar cholangiocarcinoma","volume":"24","author":"Tan","year":"2020","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib132","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/lt.21107","article-title":"Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma","volume":"13","author":"Mantel","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2025.03.007_bib133","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jamcollsurg.2019.12.037","article-title":"Living donor liver transplantation for perihilar cholangiocarcinoma: outcomes and complications","volume":"231","author":"Tan","year":"2020","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib134","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","article-title":"Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Kelley","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2025.03.007_bib135","article-title":"SWOG S1815: a phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers","author":"Shroff","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib136","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/jhbp.1219","article-title":"Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401- MITSUBA)","volume":"30","author":"Ioka","year":"2023","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jhep.2025.03.007_bib137","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1200\/JCO.21.00679","article-title":"Modified FOLFIRINOX versus CISGEM chemotherapy for patients with advanced biliary tract cancer (PRODIGE 38 AMEBICA): a randomized phase II study","volume":"40","author":"Phelip","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib138","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1200\/JCO.23.01566","article-title":"Nanoliposomal irinotecan with fluorouracil and leucovorin or gemcitabine plus cisplatin in advanced cholangiocarcinoma: a phase II study of the AIO hepatobiliary-YMO cancer groups (NIFE-AIO-YMO HEP-0315)","volume":"42","author":"Ettrich","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib139","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1470-2045(21)00027-9","article-title":"Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial","volume":"22","author":"Lamarca","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib140","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S2468-1253(24)00119-5","volume":"9","author":"Vogel","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.03.007_bib141","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jamaoncol.2023.0016","article-title":"Treatment with liposomal irinotecan plus fluorouracil and leucovorin for patients with previously treated metastatic biliary tract cancer: the phase 2b NIFTY randomized clinical trial","volume":"9","author":"Hyung","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2025.03.013","article-title":"Liposomal irinotecan for previously treated patients with biliary tract cancer: a pooled analysis of NIFTY and NALIRICC trials","author":"Yoo","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.03.007_bib143","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2206834","article-title":"Futibatinib for FGFR2-rearranged intrahepatic cholangiocarcinoma","volume":"388","author":"Goyal","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2025.03.007_bib144","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","article-title":"Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib145","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1470-2045(20)30157-1","article-title":"Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib146","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S1470-2045(20)30321-1","article-title":"Dabrafenib plus trametinib in patients with BRAF(V600E)-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial","volume":"21","author":"Subbiah","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib147","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/s41591-023-02321-8","article-title":"Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial","volume":"29","author":"Subbiah","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2025.03.007_bib148","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.3008","article-title":"Cobimetinib plus vemurafenib (C+V) in patients (Pts) with solid tumors with BRAF V600E\/d\/k\/R mutation: results from the targeted agent and profiling utilization registry (TAPUR) study","volume":"40","author":"Meric-Bernstam","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib149","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2468-1253(22)00335-1","article-title":"Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19-14)","volume":"8","author":"Lee","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.03.007_bib150","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1200\/JCO.23.02078","article-title":"Pertuzumab plus trastuzumab in patients with biliary tract cancer with ERBB2\/3 alterations: results from the targeted agent and profiling utilization registry study","volume":"42","author":"Cannon","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib151","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S1470-2045(23)00242-5","article-title":"Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study","volume":"24","author":"Harding","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib152","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41467-023-36399-y","article-title":"Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers","volume":"14","author":"Harding","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2025.03.007_bib153","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S1470-2045(21)00336-3","article-title":"Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study","volume":"22","author":"Javle","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib154","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1200\/JCO.23.00606","article-title":"Tucatinib and trastuzumab for previously treated human epidermal growth factor receptor 2-positive metastatic biliary tract cancer (SGNTUC-019): a phase II basket study","volume":"41","author":"Nakamura","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib155","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1200\/JCO.23.02010","article-title":"Trastuzumab deruxtecan in human epidermal growth factor receptor 2-expressing biliary tract cancer (HERB; NCCH1805): a multicenter, single-arm, phase II trial","volume":"42","author":"Ohba","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib156","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1200\/JCO.23.02005","article-title":"Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing solid tumors: primary results from the DESTINY-PanTumor02 phase II trial","volume":"42","author":"Meric-Bernstam","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib157","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(19)30691-6","article-title":"Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials","volume":"21","author":"Doebele","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib158","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1470-2045(19)30856-3","article-title":"Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1\/2 clinical trials","volume":"21","author":"Hong","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib159","doi-asserted-by":"crossref","first-page":"S787","DOI":"10.1016\/j.annonc.2023.09.2405","article-title":"1372P Repotrectinib in patients (pts) with NTRK fusion-positive (NTRK+) advanced solid tumors, including NSCLC: update from the phase I\/II TRIDENT-1 trial","volume":"34","author":"Solomon","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib160","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S1470-2045(22)00541-1","article-title":"Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1\/2, open-label, basket trial","volume":"23","author":"Subbiah","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib161","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.23.00434","article-title":"Adagrasib in advanced solid tumors harboring a KRAS(G12C) mutation","author":"Bekaii-Saab","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib162","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1917239","article-title":"KRAS(G12C) inhibition with sotorasib in advanced solid tumors","volume":"383","author":"Hong","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2025.03.007_bib163","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.105","article-title":"Efficacy and safety of zenocutuzumab, a HER2 x HER3 bispecific antibody, across advanced NRG1 fusion (NRG1+) cancers","volume":"40","author":"Schram","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib164","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.3006","article-title":"CRESTONE: initial efficacy and safety of seribantumab in solid tumors harboring NRG1 fusions","volume":"40","author":"Carrizosa","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib165","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib166","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(22)02038-4","article-title":"Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial","volume":"401","author":"Nakachi","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2025.03.007_bib167","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1200\/JCO.18.00050","article-title":"Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): a randomized phase III study","volume":"37","author":"Edeline","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib168","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/bjs.10776","article-title":"Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer","volume":"105","author":"Ebata","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib169","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejca.2022.01.009","article-title":"Individual patient data meta-analysis of adjuvant gemcitabine-based chemotherapy for biliary tract cancer: combined analysis of the BCAT and PRODIGE-12 studies","volume":"164","author":"Edeline","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jhep.2025.03.007_bib170","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1097\/HEP.0000000000000046","article-title":"Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trial","volume":"77","author":"Jeong","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.03.007_bib171","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/HEP.0000000000000301","article-title":"Adjuvant treatment for biliary tract tumors: lost in a maze?","volume":"77","author":"Lamarca","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.03.007_bib172","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1200\/JCO.21.02568","article-title":"Long-term outcomes and exploratory analyses of the randomized phase III BILCAP study","volume":"40","author":"Bridgewater","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib173","doi-asserted-by":"crossref","first-page":"e853","DOI":"10.1016\/j.ijrobp.2010.12.019","article-title":"Role of adjuvant chemoradiotherapy for resected extrahepatic biliary tract cancer","volume":"81","author":"Kim","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jhep.2025.03.007_bib174","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1245\/s10434-008-9998-7","article-title":"Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone","volume":"15","author":"Borghero","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib175","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1007\/s00432-021-03524-7","article-title":"Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma","volume":"147","author":"Im","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib176","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","article-title":"Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis","volume":"30","author":"Horgan","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib177","article-title":"Clinical efficacy of adjuvant treatments for patients with resected biliary tract cancer: a systematic review and network meta-analysis","volume":"12","author":"Chen","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.jhep.2025.03.007_bib178","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1200\/JCO.2014.60.2219","article-title":"SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma","volume":"33","author":"Ben-Josef","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib179","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0903230","article-title":"Preoperative biliary drainage for cancer of the head of the pancreas","volume":"362","author":"van der Gaag","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2025.03.007_bib180","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.suc.2017.09.005","article-title":"Preoperative stenting for benign and malignant periampullary diseases: unnecessary if not harmful","volume":"98","author":"Gholami","year":"2018","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.jhep.2025.03.007_bib181","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005444.pub2","article-title":"Preoperative biliary drainage for obstructive jaundice","author":"Wang","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jhep.2025.03.007_bib182","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1055\/a-0659-9864","article-title":"Endoscopic biliary stenting: indications, choice of stents, and results: European society of gastrointestinal endoscopy (ESGE) clinical guideline - updated october 2017","volume":"50","author":"Dumonceau","year":"2018","journal-title":"Endoscopy"},{"key":"10.1016\/j.jhep.2025.03.007_bib183","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jamcollsurg.2015.04.009","article-title":"Outcomes after resection of intrahepatic cholangiocarcinoma: external validation and comparison of prognostic models","volume":"221","author":"Doussot","year":"2015","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib184","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1007\/s10147-021-01926-8","article-title":"Negative prognostic outcomes of percutaneous transhepatic biliary drainage in distal cholangiocarcinoma: a retrospective analysis using propensity score matching","volume":"26","author":"Matsunaga","year":"2021","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib185","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.amjsurg.2017.01.010","article-title":"Prognostic impact of type of preoperative biliary drainage in patients with distal cholangiocarcinoma","volume":"214","author":"Miura","year":"2017","journal-title":"Am J Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib186","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s00535-015-1140-6","article-title":"Percutaneous biliary drainage is oncologically inferior to endoscopic drainage: a propensity score matching analysis in resectable distal cholangiocarcinoma","volume":"51","author":"Komaya","year":"2016","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.03.007_bib187","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000528020","article-title":"Comparison of efficacy and safety between endoscopic retrograde cholangiopancreatography and percutaneous transhepatic cholangial drainage for the treatment of malignant obstructive jaundice: a systematic review and meta-analysis","volume":"104","author":"Pang","year":"2023","journal-title":"Digestion"},{"key":"10.1016\/j.jhep.2025.03.007_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2022.100163","article-title":"Endoscopic biliary darinage (EBD) versus percutaneous transhepatic biliary drainage (PTBD) for biliary drainage in patients with perihilar cholangiocarcinoma (PCCA): a systematic review and meta-analysis","volume":"78","author":"Moll","year":"2023","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.jhep.2025.03.007_bib189","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S2468-1253(18)30234-6","article-title":"Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial","volume":"3","author":"Coelen","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.03.007_bib190","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/1553350620911291","article-title":"Endoscopic versus percutaneous preoperative biliary drainage in patients with klatskin tumor undergoing curative surgery: a systematic review and meta-analysis of short-term and long-term outcomes","volume":"27","author":"Hajibandeh","year":"2020","journal-title":"Surg Innov"},{"key":"10.1016\/j.jhep.2025.03.007_bib191","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.hpb.2022.10.009","article-title":"Long-term follow-up of a randomized trial of biliary drainage in perihilar cholangiocarcinoma","volume":"25","author":"Nooijen","year":"2023","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jhep.2025.03.007_bib192","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12957-019-1656-y","article-title":"A systematic review of the comparison of the incidence of seeding metastasis between endoscopic biliary drainage and percutaneous transhepatic biliary drainage for resectable malignant biliary obstruction","volume":"17","author":"Wang","year":"2019","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.jhep.2025.03.007_bib193","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/jhbp.1162","article-title":"Metal vs plastic stents for preoperative biliary drainage in patients with periampullary cancer: an updated systematic review and meta-analysis","volume":"30","author":"Watanabe","year":"2023","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jhep.2025.03.007_bib194","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12876-023-02874-5","article-title":"Comparison of metal versus plastic stent for preoperative biliary drainage in patients with pancreatic cancer undergoing neoadjuvant therapy: a meta-analysis and systematic review","volume":"23","author":"Lyu","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2025.03.007_bib195","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00535-010-0298-1","article-title":"Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma","volume":"46","author":"Kawakami","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.03.007_bib196","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/SLA.0b013e318262b2e9","article-title":"Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma: a retrospective study of efficacy and risk factors related to complications","volume":"257","author":"Kawashima","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2025.03.007_bib197","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1477-2574.2012.00588.x","article-title":"Metal stents: a bridge to surgery in hilar cholangiocarcinoma","volume":"15","author":"Grunhagen","year":"2013","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jhep.2025.03.007_bib198","first-page":"21","article-title":"Predictive factors for survival in patients with inoperable Klatskin tumors","volume":"53","author":"Arvanitakis","year":"2006","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jhep.2025.03.007_bib199","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10620-018-5277-z","article-title":"Biliary decompression in perihilar cholangiocarcinoma improves survival: a single-center retrospective analysis","volume":"64","author":"Cassani","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2025.03.007_bib200","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0016-5107(02)70356-8","article-title":"Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life","volume":"56","author":"Abraham","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2025.03.007_bib201","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.21873\/invivo.11964","article-title":"How to choose between percutaneous transhepatic and endoscopic biliary drainage in malignant obstructive jaundice: an updated systematic review and meta-analysis","volume":"34","author":"Rizzo","year":"2020","journal-title":"In Vivo"},{"key":"10.1016\/j.jhep.2025.03.007_bib202","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40644-017-0129-1","article-title":"Comparison of efficacy and complications of endoscopic and percutaneous biliary drainage in malignant obstructive jaundice: a systematic review and meta-analysis","volume":"17","author":"Duan","year":"2017","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.jhep.2025.03.007_bib203","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/den.12320","article-title":"Comparison of percutaneous transhepatic biliary drainage and endoscopic biliary drainage in the management of malignant biliary tract obstruction: a meta-analysis","volume":"27","author":"Zhao","year":"2015","journal-title":"Dig Endosc"},{"key":"10.1016\/j.jhep.2025.03.007_bib204","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1007\/s00261-021-03215-4","article-title":"Survival benefit of percutaneous transhepatic biliary drainage for malignant biliary tract obstruction-a prospective study comparing external and internal drainage techniques","volume":"46","author":"Kumar","year":"2021","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.jhep.2025.03.007_bib205","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/MCG.0b013e318272440e","article-title":"Effect of endoscopic stenting of malignant bile duct obstruction on quality of life","volume":"47","author":"Barkay","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2025.03.007_bib206","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.gie.2015.03.1980","article-title":"Self-expandable metal stents versus plastic stents for malignant biliary obstruction: a meta-analysis","volume":"82","author":"Sawas","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2025.03.007_bib207","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/ajg.2016.512","article-title":"Plastic vs. Self-expandable metal stents for palliation in malignant biliary obstruction: a series of meta-analyses","volume":"112","author":"Almadi","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.03.007_bib208","doi-asserted-by":"crossref","first-page":"13374","DOI":"10.3748\/wjg.v21.i47.13374","article-title":"Endoscopic stenting for inoperable malignant biliary obstruction: a systematic review and meta-analysis","volume":"21","author":"Zorron Pu","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.03.007_bib209","doi-asserted-by":"crossref","first-page":"8638","DOI":"10.3748\/wjg.v19.i46.8638","article-title":"Randomized trial in malignant biliary obstruction: plastic vs partially covered metal stents","volume":"19","author":"Moses","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.03.007_bib210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cgh.2012.10.019","article-title":"No benefit of covered vs uncovered self-expandable metal stents in patients with malignant distal biliary obstruction: a meta-analysis","volume":"11","author":"Almadi","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.03.007_bib211","article-title":"Covered versus uncovered self-expandable metal stents for managing malignant distal biliary obstruction: a meta-analysis","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2025.03.007_bib212","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/den.14260","article-title":"Covered versus uncovered metal stent for endoscopic drainage of a malignant distal biliary obstruction: meta-analysis","volume":"34","author":"Yamashita","year":"2022","journal-title":"Dig Endosc"},{"key":"10.1016\/j.jhep.2025.03.007_bib213","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1055\/s-0043-125062","article-title":"Covered vs. uncovered self-expandable metal stents for malignant distal biliary strictures: a systematic review and meta-analysis","volume":"50","author":"Tringali","year":"2018","journal-title":"Endoscopy"},{"key":"10.1016\/j.jhep.2025.03.007_bib214","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.gie.2023.10.023","article-title":"Fully covered versus partially covered self-expandable metal stents for palliation of distal malignant biliary obstruction: a systematic review and meta-analysis","volume":"99","author":"Vanella","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2025.03.007_bib215","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/00365521.2023.2282375","article-title":"ERCP for the initial management of malignant biliary obstruction - real world data on 596 procedures","volume":"59","author":"Mikalsen","year":"2024","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.03.007_bib216","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.gie.2016.12.023","article-title":"Efficacy and safety of EUS-guided biliary drainage in comparison with percutaneous biliary drainage when ERCP fails: a systematic review and meta-analysis","volume":"85","author":"Sharaiha","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2025.03.007_bib217","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133291","article-title":"Methods for drainage of distal malignant biliary obstruction after ERCP failure: a systematic review and network meta-analysis","volume":"14","author":"Facciorusso","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhep.2025.03.007_bib218","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/SLE.0000000000001192","article-title":"Endoscopic ultrasound-guided versus percutaneous transhepatic biliary drainage after failed ERCP: a systematic review and meta-analysis","volume":"33","author":"Giri","year":"2023","journal-title":"Surg Laparosc Endosc Percutan Tech"},{"key":"10.1016\/j.jhep.2025.03.007_bib219","doi-asserted-by":"crossref","first-page":"E1563","DOI":"10.1055\/a-0998-8129","article-title":"Endoscopic ultrasound-guided biliary drainage for distal malignant obstruction: a systematic review and meta-analysis of randomized trials","volume":"7","author":"Miller","year":"2019","journal-title":"Endosc Int Open"},{"key":"10.1016\/j.jhep.2025.03.007_bib220","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2023.07.024","article-title":"Endoscopic ultrasound-guided biliary drainage of first intent with a lumen-apposing metal stent vs endoscopic retrograde cholangiopancreatography in malignant distal biliary obstruction: a multicenter randomized controlled study (ELEMENT trial)","volume":"165","author":"Chen","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.03.007_bib221","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1055\/s-0034-1391988","article-title":"Endoscopic ultrasound-guided biliary drainage after failed ERCP: cumulative experience of 101 procedures at a single center","volume":"47","author":"Poincloux","year":"2015","journal-title":"Endoscopy"},{"key":"10.1016\/j.jhep.2025.03.007_bib222","doi-asserted-by":"crossref","first-page":"683","DOI":"10.17235\/reed.2019.6225\/2019","article-title":"Endoscopic biliary drainage in unresectable biliary obstruction: the role of endoscopic ultrasound-guidance in a cohort study","volume":"111","author":"Puga","year":"2019","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.jhep.2025.03.007_bib223","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s00464-019-06871-2","article-title":"Comparing the efficacy of initial percutaneous transhepatic biliary drainage and endoscopic retrograde cholangiopancreatography with stenting for relief of biliary obstruction in unresectable cholangiocarcinoma","volume":"34","author":"O\u2019Brien","year":"2020","journal-title":"Surg Endosc"},{"key":"10.1016\/j.jhep.2025.03.007_bib224","first-page":"893","article-title":"Percutaneous transhepatic cholangiography and drainage and endoscopic retrograde cholangiopancreatograph for hilar cholangiocarcinoma: which one is preferred?","volume":"112","author":"Zhu","year":"2020","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.jhep.2025.03.007_bib225","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jvir.2012.09.019","article-title":"Endoscopic or percutaneous biliary drainage for Klatskin tumors?","volume":"24","author":"Walter","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jhep.2025.03.007_bib226","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.gie.2008.04.005","article-title":"Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach","volume":"69","author":"Paik","year":"2009","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2025.03.007_bib227","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.3748\/wjg.v13.i29.3948","article-title":"Optimal biliary drainage for inoperable Klatskin\u2019s tumor based on Bismuth type","volume":"13","author":"Lee","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.03.007_bib228","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.cgh.2008.03.028","article-title":"Endoscopic or percutaneous biliary drainage for gallbladder cancer: a randomized trial and quality of life assessment","volume":"6","author":"Saluja","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.03.007_bib229","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1148\/radiol.2243011517","article-title":"Percutaneous self-expanding metal stents versus endoscopic polyethylene endoprostheses for treating malignant biliary obstruction: randomized clinical trial","volume":"225","author":"Pinol","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2025.03.007_bib230","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4726078","article-title":"Endoscopic versus percutaneous biliary drainage in palliation of advanced malignant hilar obstruction: a meta-analysis and systematic review","volume":"2016","author":"Moole","year":"2016","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.03.007_bib231","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.gie.2012.02.048","article-title":"Efficacy of metal and plastic stents in unresectable complex hilar cholangiocarcinoma: a randomized controlled trial","volume":"76","author":"Sangchan","year":"2012","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2025.03.007_bib232","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-2007-1010295","article-title":"Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. A prospective and randomized trial","volume":"25","author":"Wagner","year":"1993","journal-title":"Endoscopy"},{"key":"10.1016\/j.jhep.2025.03.007_bib233","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00534-012-0508-8","article-title":"Metallic stents are more efficacious than plastic stents in unresectable malignant hilar biliary strictures: a randomized controlled trial","volume":"20","author":"Mukai","year":"2013","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jhep.2025.03.007_bib234","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.clinre.2012.12.002","article-title":"Metal versus plastic stents for malignant biliary obstruction: an update meta-analysis","volume":"37","author":"Hong","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhep.2025.03.007_bib235","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/ajg.2016.585","article-title":"Lack in standardized reporting of biliary stents: a meta-analysis complicated by the inconsistency","volume":"112","author":"Hamada","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.03.007_bib236","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.gie.2023.12.006","article-title":"Biliary drainage in hilar and perihilar cholangiocarcinoma; 25-year experience at a tertiary cancer center","volume":"99","author":"Al Nakshabandi","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2025.03.007_bib237","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.hpb.2023.03.011","article-title":"Long-term efficacy of metal versus plastic stents in inoperable perihilar cholangiocarcinoma; a multicenter retrospective propensity score matched comparison","volume":"25","author":"Fritzsche","year":"2023","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jhep.2025.03.007_bib238","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.1055\/a-2204-8316","article-title":"Intraductal radiofrequency ablation plus biliary stent versus stent alone for malignant biliary obstruction: a systematic review and meta-analysis","volume":"12","author":"de Oliveira Veras","year":"2024","journal-title":"Endosc Int Open"},{"key":"10.1016\/j.jhep.2025.03.007_bib239","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16071372","article-title":"The impact of radiofrequency ablation on survival outcomes and stent patency in patients with unresectable cholangiocarcinoma: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Balducci","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhep.2025.03.007_bib240","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.gie.2010.09.031","article-title":"Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction","volume":"73","author":"Steel","year":"2011","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2025.03.007_bib241","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4253\/wjge.v14.i3.106","article-title":"Role of intraluminal brachytherapy in palliation of biliary obstruction in cholangiocarcinoma: a brief review","volume":"14","author":"Khosla","year":"2022","journal-title":"World J Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2025.03.007_bib242","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.3748\/wjg.v26.i31.4589","article-title":"Feasibility and efficacy evaluation of metallic biliary stents eluting gemcitabine and cisplatin for extrahepatic cholangiocarcinoma","volume":"26","author":"Xiao","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2025.03.007_bib243","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17175-7","article-title":"CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma","volume":"7","author":"Loosen","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2025.03.007_bib244","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.ejca.2015.04.011","article-title":"Decline in CA19-9 during chemotherapy predicts survival in four independent cohorts of patients with inoperable bile duct cancer","volume":"51","author":"Grunnet","year":"2015","journal-title":"Eur J Cancer"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882782500162X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882782500162X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T01:07:30Z","timestamp":1766192850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882782500162X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":244,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S016882782500162X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2025.03.007","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2025.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}